search
Back to results

Single Versus Multiple Deployment of Metallic Stents for Inoperable Malignant Hilar Biliary Obstruction

Primary Purpose

Klatskin Tumor

Status
Completed
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Metallic stent deployment in hilar obstruction
Sponsored by
Soon Chun Hyang University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Klatskin Tumor focused on measuring Hilar tumor, Metal stent, Single, Multiple

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • age > 18 years
  • inoperable hilar malignancy

Exclusion Criteria:

  • age under 18 years
  • uncontrolled coagulopathy
  • inability to provide informed consent

Sites / Locations

  • Tae Hoon Lee

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Single stent deployment

Multiple stent deployment

Arm Description

Metallic stent deployment in hilar obstruction. Insertion of metallic stent to the dominant targeted duct such as right anterior (segments V and VIII), right posterior (segments VI and VII) or left (segments II-IV).

Metallic stent deployment in hilar obstruction. Insertion of multiple metallic stent to the dominant targeted duct such as right anterior (segments V and VIII), right posterior (segments VI and VII) or left (segments II-IV).

Outcomes

Primary Outcome Measures

Reintervention rate when stents occluded
When the stents occluded after successful single or multiple stent deployment, the outcome measure is assessed.

Secondary Outcome Measures

Technical success of single or multiple stents
When the bilirubin level decrease more than 50% within one week or 75% within one month.

Full Information

First Posted
June 13, 2014
Last Updated
February 27, 2017
Sponsor
Soon Chun Hyang University
search

1. Study Identification

Unique Protocol Identification Number
NCT02166970
Brief Title
Single Versus Multiple Deployment of Metallic Stents for Inoperable Malignant Hilar Biliary Obstruction
Official Title
Single Versus Multiple Deployment of Metallic Stents for Inoperable Malignant Hilar Biliary Obstruction: A Multicenter Prospective Randomized Study
Study Type
Interventional

2. Study Status

Record Verification Date
February 2017
Overall Recruitment Status
Completed
Study Start Date
March 1, 2014 (Actual)
Primary Completion Date
February 28, 2016 (Actual)
Study Completion Date
October 30, 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Soon Chun Hyang University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
In Bismuth II-IV hilar cholangiocarcinoma patients with a predicted survival of longer than 3 months, metallic stent performance is superior to plastic stenting for palliation with respect to outcomes and cost-effectiveness. However, the optimal stent type and the extent of drainage are issues that remain to be definitively decided. The optimal endoscopic management strategy is contentious. The investigators conduct the present study to prospectively in multi-centers compare unilateral (single) with bilateral (multiple) deployment in inoperable malignant biliary obstructions to clarify the clinical outcomes of these two deployment methods using metallic stents.
Detailed Description
In Bismuth II-IV hilar cholangiocarcinoma patients with a predicted survival of longer than 3 months, metallic stent performance is superior to plastic stenting for palliation with respect to outcomes and cost-effectiveness. However, the optimal stent type and the extent of drainage are issues that remain to be definitively decided. The optimal endoscopic management strategy is contentious. The investigators conduct the present study to prospectively in multi-centers compare unilateral (single) with bilateral (multiple) deployment in inoperable malignant biliary obstructions to clarify the clinical outcomes of these two deployment methods using metallic stents. First as an unilateral or bilateral stent will be deployed according to criteria. In bilateral group, stent-in-stent or side-by-side deployment will be included.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Klatskin Tumor
Keywords
Hilar tumor, Metal stent, Single, Multiple

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Care Provider
Allocation
Randomized
Enrollment
130 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Single stent deployment
Arm Type
Experimental
Arm Description
Metallic stent deployment in hilar obstruction. Insertion of metallic stent to the dominant targeted duct such as right anterior (segments V and VIII), right posterior (segments VI and VII) or left (segments II-IV).
Arm Title
Multiple stent deployment
Arm Type
Active Comparator
Arm Description
Metallic stent deployment in hilar obstruction. Insertion of multiple metallic stent to the dominant targeted duct such as right anterior (segments V and VIII), right posterior (segments VI and VII) or left (segments II-IV).
Intervention Type
Device
Intervention Name(s)
Metallic stent deployment in hilar obstruction
Other Intervention Name(s)
Single stent insertion, Multiple stent insertion using stent-in-stent method, Multiple stent insertion using side-by-side method
Intervention Description
Single stent insertion: metal stent deployment to right or left intrahepatic duct Multiple stenting: Stent-in-stent or side-by-side deployment
Primary Outcome Measure Information:
Title
Reintervention rate when stents occluded
Description
When the stents occluded after successful single or multiple stent deployment, the outcome measure is assessed.
Time Frame
2 years
Secondary Outcome Measure Information:
Title
Technical success of single or multiple stents
Description
When the bilirubin level decrease more than 50% within one week or 75% within one month.
Time Frame
1 month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: age > 18 years inoperable hilar malignancy Exclusion Criteria: age under 18 years uncontrolled coagulopathy inability to provide informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tae Hoon Lee, MD, PhD
Organizational Affiliation
SoonChunHyang University School of Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Tae Hoon Lee
City
Cheonan
ZIP/Postal Code
330721
Country
Korea, Republic of

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
28479493
Citation
Lee TH, Kim TH, Moon JH, Lee SH, Choi HJ, Hwangbo Y, Hyun JJ, Choi JH, Jeong S, Kim JH, Park DH, Han JH, Park SH. Bilateral versus unilateral placement of metal stents for inoperable high-grade malignant hilar biliary strictures: a multicenter, prospective, randomized study (with video). Gastrointest Endosc. 2017 Nov;86(5):817-827. doi: 10.1016/j.gie.2017.04.037. Epub 2017 May 4.
Results Reference
derived

Learn more about this trial

Single Versus Multiple Deployment of Metallic Stents for Inoperable Malignant Hilar Biliary Obstruction

We'll reach out to this number within 24 hrs